| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adaptor Proteins, Signal Transducing | 11 | 2021 | 619 | 1.390 |
Why?
|
| Arrestins | 13 | 2003 | 24 | 1.100 |
Why?
|
| Transcription Factors | 16 | 2021 | 2406 | 1.090 |
Why?
|
| LIM Domain Proteins | 8 | 2013 | 64 | 1.010 |
Why?
|
| Lysophospholipids | 8 | 2012 | 45 | 0.950 |
Why?
|
| Carrier Proteins | 13 | 2021 | 993 | 0.810 |
Why?
|
| Cell Movement | 6 | 2013 | 876 | 0.800 |
Why?
|
| Receptors, Lysophosphatidic Acid | 6 | 2012 | 10 | 0.790 |
Why?
|
| DNA-Binding Proteins | 17 | 2021 | 1939 | 0.760 |
Why?
|
| Nuclear Proteins | 14 | 2021 | 1211 | 0.660 |
Why?
|
| Apoptosis | 12 | 2014 | 1827 | 0.580 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2022 | 280 | 0.580 |
Why?
|
| Phosphorylation | 20 | 2021 | 1571 | 0.520 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 9 | 2021 | 82 | 0.510 |
Why?
|
| Actins | 3 | 2021 | 321 | 0.500 |
Why?
|
| Signal Transduction | 13 | 2021 | 4686 | 0.460 |
Why?
|
| E2F1 Transcription Factor | 9 | 2020 | 51 | 0.440 |
Why?
|
| Proteasome Endopeptidase Complex | 8 | 2013 | 241 | 0.440 |
Why?
|
| Receptors, Adrenergic, beta-2 | 5 | 2002 | 57 | 0.420 |
Why?
|
| Protein-Tyrosine Kinases | 5 | 2011 | 219 | 0.400 |
Why?
|
| Endocytosis | 6 | 2003 | 121 | 0.400 |
Why?
|
| Breast Neoplasms | 4 | 2022 | 2602 | 0.390 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 57 | 0.380 |
Why?
|
| Protein Binding | 12 | 2020 | 1652 | 0.350 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2013 | 587 | 0.340 |
Why?
|
| Transcriptional Activation | 3 | 2011 | 419 | 0.330 |
Why?
|
| fas Receptor | 1 | 2010 | 40 | 0.320 |
Why?
|
| Cell Cycle Proteins | 9 | 2021 | 710 | 0.310 |
Why?
|
| Down-Regulation | 4 | 2012 | 645 | 0.300 |
Why?
|
| beta-Arrestins | 13 | 2003 | 30 | 0.270 |
Why?
|
| Cell Line | 16 | 2020 | 2552 | 0.270 |
Why?
|
| Gene Expression Regulation | 7 | 2007 | 2323 | 0.270 |
Why?
|
| Cell Line, Tumor | 12 | 2021 | 3748 | 0.270 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2020 | 480 | 0.260 |
Why?
|
| Feedback, Physiological | 1 | 2007 | 67 | 0.260 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2007 | 73 | 0.260 |
Why?
|
| Mice | 25 | 2021 | 18301 | 0.240 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2009 | 588 | 0.230 |
Why?
|
| DNA Repair | 3 | 2021 | 571 | 0.220 |
Why?
|
| Animals | 32 | 2021 | 33912 | 0.220 |
Why?
|
| Ovarian Neoplasms | 3 | 2021 | 420 | 0.210 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 5 | 2021 | 94 | 0.210 |
Why?
|
| DNA Damage | 7 | 2021 | 511 | 0.210 |
Why?
|
| Receptors, Opioid, mu | 2 | 2000 | 34 | 0.190 |
Why?
|
| Clathrin | 2 | 2002 | 21 | 0.190 |
Why?
|
| Morphine | 2 | 2000 | 81 | 0.190 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2012 | 289 | 0.190 |
Why?
|
| DNA Replication | 4 | 2021 | 355 | 0.190 |
Why?
|
| NIH 3T3 Cells | 4 | 2007 | 91 | 0.190 |
Why?
|
| HEK293 Cells | 4 | 2014 | 801 | 0.190 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 3 | 1999 | 105 | 0.190 |
Why?
|
| Cyclin-Dependent Kinase 2 | 2 | 2020 | 53 | 0.190 |
Why?
|
| src-Family Kinases | 3 | 2011 | 92 | 0.190 |
Why?
|
| Checkpoint Kinase 1 | 2 | 2021 | 26 | 0.180 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2021 | 821 | 0.180 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2021 | 27 | 0.170 |
Why?
|
| Transfection | 9 | 2008 | 962 | 0.170 |
Why?
|
| B7-H1 Antigen | 1 | 2021 | 136 | 0.160 |
Why?
|
| Cell Adhesion | 3 | 2014 | 308 | 0.160 |
Why?
|
| 14-3-3 Proteins | 2 | 2014 | 56 | 0.160 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2000 | 88 | 0.150 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2017 | 722 | 0.150 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 13 | 2 | 2011 | 9 | 0.150 |
Why?
|
| Disease Progression | 2 | 2022 | 2200 | 0.150 |
Why?
|
| Humans | 36 | 2022 | 131163 | 0.150 |
Why?
|
| rho GTP-Binding Proteins | 2 | 2014 | 71 | 0.150 |
Why?
|
| Adipocytes | 3 | 1996 | 178 | 0.150 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2021 | 209 | 0.150 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2021 | 354 | 0.140 |
Why?
|
| Carcinogenesis | 1 | 2021 | 336 | 0.140 |
Why?
|
| Receptor, IGF Type 1 | 1 | 1998 | 93 | 0.140 |
Why?
|
| Amino Acid Motifs | 4 | 2020 | 189 | 0.130 |
Why?
|
| Tyrosine | 2 | 2010 | 142 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 597 | 0.130 |
Why?
|
| Casein Kinase II | 2 | 2011 | 12 | 0.130 |
Why?
|
| Analgesics, Opioid | 2 | 2000 | 546 | 0.130 |
Why?
|
| Enzyme Activation | 5 | 2008 | 576 | 0.130 |
Why?
|
| Glioma | 2 | 2013 | 494 | 0.120 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2021 | 478 | 0.120 |
Why?
|
| Serine | 4 | 2002 | 161 | 0.120 |
Why?
|
| Oxidative Stress | 1 | 2020 | 791 | 0.110 |
Why?
|
| Neoplasm Invasiveness | 3 | 2014 | 631 | 0.110 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2021 | 750 | 0.110 |
Why?
|
| Models, Biological | 3 | 2010 | 1371 | 0.110 |
Why?
|
| Mice, Nude | 2 | 2014 | 700 | 0.110 |
Why?
|
| rho Guanine Nucleotide Dissociation Inhibitor alpha | 1 | 2014 | 9 | 0.110 |
Why?
|
| Gene Expression | 3 | 2021 | 1481 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2021 | 2026 | 0.100 |
Why?
|
| Cytosol | 2 | 2013 | 135 | 0.100 |
Why?
|
| Ubiquitin | 2 | 2012 | 128 | 0.100 |
Why?
|
| Cell Nucleus | 3 | 2013 | 556 | 0.100 |
Why?
|
| Zyxin | 1 | 2013 | 3 | 0.100 |
Why?
|
| Molecular Sequence Data | 7 | 2009 | 3464 | 0.100 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2013 | 19 | 0.100 |
Why?
|
| LIM-Homeodomain Proteins | 1 | 2013 | 28 | 0.100 |
Why?
|
| Cell Growth Processes | 1 | 2013 | 62 | 0.100 |
Why?
|
| Amino Acid Sequence | 6 | 2009 | 2395 | 0.100 |
Why?
|
| Mitosis | 1 | 1993 | 191 | 0.090 |
Why?
|
| Adipose Tissue | 2 | 1994 | 502 | 0.090 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2012 | 62 | 0.090 |
Why?
|
| Mutation, Missense | 1 | 2017 | 919 | 0.090 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2012 | 26 | 0.090 |
Why?
|
| Transplantation, Heterologous | 1 | 2013 | 255 | 0.090 |
Why?
|
| Radiation Tolerance | 1 | 2012 | 61 | 0.090 |
Why?
|
| Cell Differentiation | 4 | 1996 | 1928 | 0.090 |
Why?
|
| 3T3 Cells | 5 | 1996 | 117 | 0.090 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 5 | 1996 | 41 | 0.090 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 713 | 0.090 |
Why?
|
| S Phase | 4 | 2020 | 76 | 0.090 |
Why?
|
| Focal Adhesions | 1 | 2011 | 14 | 0.090 |
Why?
|
| RNA, Small Interfering | 4 | 2012 | 664 | 0.080 |
Why?
|
| STAT Transcription Factors | 1 | 2011 | 24 | 0.080 |
Why?
|
| Receptors, Angiotensin | 2 | 2001 | 20 | 0.080 |
Why?
|
| Telomere Homeostasis | 1 | 2011 | 48 | 0.080 |
Why?
|
| Cadherins | 1 | 2012 | 182 | 0.080 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 2010 | 6 | 0.080 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2011 | 135 | 0.080 |
Why?
|
| Osteoclasts | 1 | 2011 | 69 | 0.080 |
Why?
|
| Polycythemia Vera | 1 | 2011 | 41 | 0.080 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2011 | 94 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 1545 | 0.080 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2011 | 105 | 0.080 |
Why?
|
| Transcription Factor RelA | 1 | 2010 | 49 | 0.080 |
Why?
|
| Cytoskeleton | 1 | 2011 | 166 | 0.080 |
Why?
|
| Up-Regulation | 1 | 2013 | 825 | 0.080 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2010 | 113 | 0.080 |
Why?
|
| beta-Arrestin 2 | 5 | 2001 | 9 | 0.080 |
Why?
|
| Mice, Knockout | 6 | 2021 | 3819 | 0.080 |
Why?
|
| Phosphoproteins | 3 | 2012 | 448 | 0.080 |
Why?
|
| Doxorubicin | 6 | 2009 | 288 | 0.080 |
Why?
|
| Telomere | 1 | 2011 | 219 | 0.080 |
Why?
|
| Two-Hybrid System Techniques | 3 | 2004 | 60 | 0.070 |
Why?
|
| Triglycerides | 1 | 1992 | 602 | 0.070 |
Why?
|
| NF-kappa B | 1 | 2011 | 440 | 0.070 |
Why?
|
| GTP-Binding Proteins | 4 | 2009 | 156 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2000 | 183 | 0.070 |
Why?
|
| Glutathione Transferase | 3 | 2004 | 148 | 0.070 |
Why?
|
| Antineoplastic Agents | 3 | 2021 | 1826 | 0.070 |
Why?
|
| COS Cells | 4 | 2002 | 253 | 0.070 |
Why?
|
| Glioblastoma | 1 | 2013 | 371 | 0.070 |
Why?
|
| RNA | 1 | 1992 | 517 | 0.070 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2001 | 157 | 0.070 |
Why?
|
| Neoplasms | 2 | 2014 | 3016 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2008 | 1205 | 0.070 |
Why?
|
| Cell Division | 2 | 2020 | 718 | 0.070 |
Why?
|
| Female | 7 | 2022 | 70963 | 0.070 |
Why?
|
| Caspase 3 | 1 | 2007 | 121 | 0.070 |
Why?
|
| Hematologic Neoplasms | 1 | 2011 | 315 | 0.070 |
Why?
|
| Chromatin | 2 | 2021 | 499 | 0.060 |
Why?
|
| Protein Phosphatase 1 | 1 | 2007 | 53 | 0.060 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2007 | 157 | 0.060 |
Why?
|
| Mutation | 6 | 2009 | 6099 | 0.060 |
Why?
|
| Ubiquitination | 2 | 2021 | 173 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 2 | 2008 | 258 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2007 | 623 | 0.060 |
Why?
|
| Precipitin Tests | 2 | 2003 | 109 | 0.060 |
Why?
|
| Amino Acid Substitution | 2 | 2017 | 405 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 2 | 2004 | 358 | 0.060 |
Why?
|
| beta-Arrestin 1 | 3 | 2001 | 4 | 0.060 |
Why?
|
| Cisplatin | 3 | 2021 | 274 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 2 | 2012 | 300 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 2 | 2003 | 716 | 0.060 |
Why?
|
| Isoproterenol | 2 | 2002 | 85 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 5 | 2008 | 484 | 0.050 |
Why?
|
| DNA | 4 | 2004 | 1399 | 0.050 |
Why?
|
| Base Pair Mismatch | 1 | 2004 | 19 | 0.050 |
Why?
|
| In Vitro Techniques | 3 | 1994 | 808 | 0.050 |
Why?
|
| Protein Kinases | 2 | 2021 | 312 | 0.050 |
Why?
|
| DNA Repair Enzymes | 1 | 2004 | 35 | 0.050 |
Why?
|
| Fibroblasts | 4 | 2012 | 849 | 0.050 |
Why?
|
| Paxillin | 1 | 2003 | 13 | 0.050 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2003 | 24 | 0.050 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2003 | 25 | 0.050 |
Why?
|
| Point Mutation | 2 | 2002 | 333 | 0.050 |
Why?
|
| E2F Transcription Factors | 4 | 2004 | 27 | 0.050 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 2 | 2000 | 13 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 142 | 0.050 |
Why?
|
| Adenosine Triphosphatases | 1 | 2004 | 189 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 4 | 2008 | 1207 | 0.050 |
Why?
|
| Receptors, LDL | 1 | 2003 | 106 | 0.050 |
Why?
|
| Plasmids | 1 | 2003 | 449 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 303 | 0.050 |
Why?
|
| Threonine | 1 | 2002 | 62 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 1075 | 0.050 |
Why?
|
| Receptors, CCR5 | 1 | 2002 | 30 | 0.050 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2002 | 50 | 0.040 |
Why?
|
| Recombinant Proteins | 3 | 2003 | 1319 | 0.040 |
Why?
|
| CHO Cells | 3 | 2012 | 152 | 0.040 |
Why?
|
| Cricetinae | 3 | 2012 | 362 | 0.040 |
Why?
|
| Mutagenesis | 2 | 2003 | 324 | 0.040 |
Why?
|
| Lysine Acetyltransferase 5 | 1 | 2021 | 4 | 0.040 |
Why?
|
| Carcinogens | 1 | 2021 | 127 | 0.040 |
Why?
|
| Sodium-Hydrogen Exchangers | 2 | 2012 | 28 | 0.040 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2000 | 33 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2004 | 688 | 0.040 |
Why?
|
| Drug Tolerance | 1 | 2000 | 39 | 0.040 |
Why?
|
| Binding Sites | 2 | 2002 | 1133 | 0.040 |
Why?
|
| DNA Adducts | 1 | 2021 | 70 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 3 | 2014 | 975 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2004 | 697 | 0.040 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2000 | 56 | 0.040 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2020 | 25 | 0.040 |
Why?
|
| G2 Phase | 1 | 2020 | 39 | 0.040 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2021 | 89 | 0.040 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 1999 | 2 | 0.040 |
Why?
|
| E2F3 Transcription Factor | 3 | 2004 | 11 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2004 | 680 | 0.040 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2020 | 59 | 0.040 |
Why?
|
| DNA, Neoplasm | 1 | 2021 | 282 | 0.040 |
Why?
|
| Pain Threshold | 1 | 1999 | 24 | 0.040 |
Why?
|
| Sumoylation | 1 | 2020 | 47 | 0.040 |
Why?
|
| Cyclins | 1 | 2020 | 94 | 0.040 |
Why?
|
| Transcription, Genetic | 3 | 1994 | 1363 | 0.040 |
Why?
|
| Cysteine Endopeptidases | 1 | 2020 | 110 | 0.040 |
Why?
|
| Genomic Instability | 1 | 2021 | 245 | 0.040 |
Why?
|
| Naloxone | 1 | 1999 | 45 | 0.040 |
Why?
|
| Peptide Mapping | 1 | 1999 | 33 | 0.040 |
Why?
|
| Analgesia | 1 | 1999 | 44 | 0.040 |
Why?
|
| Body Temperature | 1 | 1999 | 126 | 0.040 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 1999 | 45 | 0.040 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 1999 | 6 | 0.040 |
Why?
|
| Narcotic Antagonists | 1 | 1999 | 112 | 0.040 |
Why?
|
| Feedback | 1 | 1999 | 144 | 0.030 |
Why?
|
| Pain Measurement | 1 | 1999 | 353 | 0.030 |
Why?
|
| Vesicular Transport Proteins | 1 | 1999 | 138 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 1011 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2020 | 594 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2021 | 1483 | 0.030 |
Why?
|
| Rats | 4 | 2012 | 3370 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 3 | 2003 | 4738 | 0.030 |
Why?
|
| Cell Survival | 2 | 2011 | 826 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 1999 | 573 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2017 | 239 | 0.030 |
Why?
|
| Fluoresceins | 1 | 2014 | 30 | 0.030 |
Why?
|
| Heterografts | 1 | 2014 | 191 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 358 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2014 | 209 | 0.030 |
Why?
|
| Growth Inhibitors | 1 | 1993 | 35 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1993 | 276 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1993 | 150 | 0.020 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2014 | 235 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1994 | 263 | 0.020 |
Why?
|
| DNA Fragmentation | 1 | 2012 | 53 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2012 | 64 | 0.020 |
Why?
|
| Apc5 Subunit, Anaphase-Promoting Complex-Cyclosome | 1 | 2012 | 2 | 0.020 |
Why?
|
| Anaphase-Promoting Complex-Cyclosome | 1 | 2012 | 18 | 0.020 |
Why?
|
| Time Factors | 1 | 2002 | 6196 | 0.020 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2012 | 62 | 0.020 |
Why?
|
| Leucine Zippers | 1 | 1992 | 16 | 0.020 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2012 | 95 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 1992 | 203 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 1994 | 348 | 0.020 |
Why?
|
| Caspases | 1 | 2012 | 152 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 1994 | 2550 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2012 | 157 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 1993 | 307 | 0.020 |
Why?
|
| Phosphorylase a | 1 | 2011 | 3 | 0.020 |
Why?
|
| Janus Kinase 1 | 1 | 2011 | 11 | 0.020 |
Why?
|
| Subcellular Fractions | 2 | 2004 | 89 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2011 | 159 | 0.020 |
Why?
|
| Receptor, Angiotensin, Type 1 | 2 | 2001 | 55 | 0.020 |
Why?
|
| RNA Interference | 1 | 2012 | 491 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2012 | 410 | 0.020 |
Why?
|
| Blotting, Western | 1 | 1992 | 1013 | 0.020 |
Why?
|
| Janus Kinase 2 | 1 | 2011 | 138 | 0.020 |
Why?
|
| beta-Adrenergic Receptor Kinases | 2 | 2001 | 11 | 0.020 |
Why?
|
| Lipoylation | 1 | 2009 | 5 | 0.020 |
Why?
|
| Cytoprotection | 1 | 2009 | 36 | 0.020 |
Why?
|
| Tumor Protein p73 | 1 | 2008 | 26 | 0.020 |
Why?
|
| Rad51 Recombinase | 1 | 2008 | 33 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 1992 | 892 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2004 | 2885 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2012 | 905 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2008 | 292 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2008 | 223 | 0.020 |
Why?
|
| Brain | 1 | 1999 | 3175 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2009 | 243 | 0.020 |
Why?
|
| Human papillomavirus 16 | 1 | 2006 | 97 | 0.010 |
Why?
|
| Liver | 1 | 1993 | 1796 | 0.010 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2006 | 111 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2012 | 2465 | 0.010 |
Why?
|
| Drug Stability | 1 | 2004 | 56 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2006 | 335 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2006 | 337 | 0.010 |
Why?
|
| Mismatch Repair Endonuclease PMS2 | 1 | 2004 | 10 | 0.010 |
Why?
|
| MutL Proteins | 1 | 2004 | 14 | 0.010 |
Why?
|
| Base Sequence | 2 | 2001 | 2730 | 0.010 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2004 | 52 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2004 | 130 | 0.010 |
Why?
|
| G1 Phase | 1 | 2004 | 68 | 0.010 |
Why?
|
| Immunosorbent Techniques | 1 | 2003 | 16 | 0.010 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2004 | 123 | 0.010 |
Why?
|
| E2F2 Transcription Factor | 1 | 2003 | 5 | 0.010 |
Why?
|
| E2F4 Transcription Factor | 1 | 2003 | 10 | 0.010 |
Why?
|
| BRCA1 Protein | 1 | 2003 | 78 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 787 | 0.010 |
Why?
|
| Lipoproteins | 1 | 2003 | 183 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 780 | 0.010 |
Why?
|
| Chemokine CCL5 | 1 | 2002 | 53 | 0.010 |
Why?
|
| Dietary Fats | 1 | 2003 | 278 | 0.010 |
Why?
|
| Cholesterol, HDL | 1 | 2003 | 383 | 0.010 |
Why?
|
| Biological Transport | 1 | 2002 | 329 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2003 | 403 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2002 | 277 | 0.010 |
Why?
|
| Etoposide | 1 | 2001 | 112 | 0.010 |
Why?
|
| Thymus Gland | 1 | 2001 | 104 | 0.010 |
Why?
|
| Morphine Dependence | 1 | 2000 | 1 | 0.010 |
Why?
|
| Membranes | 1 | 2000 | 14 | 0.010 |
Why?
|
| Phosphatidylinositols | 1 | 2001 | 30 | 0.010 |
Why?
|
| MAP Kinase Kinase Kinase 5 | 1 | 2000 | 7 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 10 | 1 | 2000 | 5 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2000 | 33 | 0.010 |
Why?
|
| Drug Implants | 1 | 2000 | 41 | 0.010 |
Why?
|
| Adenylyl Cyclases | 1 | 2000 | 45 | 0.010 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2001 | 21 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2001 | 356 | 0.010 |
Why?
|
| Cholesterol | 1 | 2003 | 539 | 0.010 |
Why?
|
| Endosomes | 1 | 2000 | 70 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2001 | 220 | 0.010 |
Why?
|
| Angiotensin II | 1 | 2000 | 131 | 0.010 |
Why?
|
| Brain Stem | 1 | 2000 | 108 | 0.010 |
Why?
|
| DNA Primers | 1 | 2001 | 599 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2003 | 604 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2001 | 423 | 0.010 |
Why?
|
| Cattle | 1 | 2001 | 501 | 0.010 |
Why?
|
| N-Ethylmaleimide-Sensitive Proteins | 1 | 1999 | 1 | 0.010 |
Why?
|
| src Homology Domains | 1 | 1999 | 34 | 0.010 |
Why?
|
| Receptor Cross-Talk | 1 | 1999 | 36 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 1999 | 88 | 0.010 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1999 | 79 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 1999 | 107 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2004 | 718 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 1999 | 265 | 0.010 |
Why?
|
| Calcium | 1 | 2002 | 1010 | 0.010 |
Why?
|
| Kidney | 1 | 2003 | 1282 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 1999 | 420 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1999 | 450 | 0.010 |
Why?
|
| Kinetics | 1 | 1997 | 1088 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1994 | 40 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1994 | 1105 | 0.010 |
Why?
|